Patents by Inventor Kazuo Yudo

Kazuo Yudo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Injectable solution containing therapeutic agent for osteoarthritis
    Patent number: 9200077
    Abstract: Injections for treating and preventing diseases classified as any of grade 1 to 3 according to the ICRS classification of osteoarthritis, diseases classified as any of grade 1 to 3 according to the Kellgren-Lawrence classification of osteoarthritis or diseases classified as any of grade 1 to 3 according to the Outerbridge classification of osteoarthritis contain anti-Fas IgM antibody as an active ingredient and a pharmaceutically acceptable carrier to alleviate osteoarthritis symptoms by inhibiting the production of cartilage matrix degrading enzymes and by increasing the production of cartilage matrix.
    Type: Grant
    Filed: January 27, 2011
    Date of Patent: December 1, 2015
    Assignee: AXIS, Inc.
    Inventors: Kusuki Nishioka, Kazuo Yudo
  • Therapeutic agent or preventive agent for osteoarthritis
    Patent number: 8377444
    Abstract: A method for treatment of disease classified as any of grade 1 to 3 according to the ICRS classification of osteoarthritis, any of grade 1 to 3 according to the Kellgren-Lawrence classification of osteoarthritis, or any of grade 1 to 3 according to the Outerbridge classification of osteoarthritis, the method includes a step of administrating an agent containing an anti-Fas IgM antibody as an active ingredient.
    Type: Grant
    Filed: July 31, 2009
    Date of Patent: February 19, 2013
    Assignee: AXIS Inc.
    Inventors: Kusuki Nishioka, Kazuo Yudo
  • USE FOR PRODUCTION OF THERAPEUTIC AGENT OR PROPHYLACTIC AGENT FOR OSTEOARTHRITIS
    Publication number: 20130034563
    Abstract: Methods for treating or preventing diseases classified as any of grade 1 to 3 according to the ICRS classification of osteoarthritis, classified as grade 1 to 3 according to the Kellgren-Lawrence classification of osteoarthritis, or classified as grade 1 to 3 according to the Outerbridge classification of osteoarthritis, include administering to a subject in need thereof a therapeutically effective amount of treatment agents or preventive agents containing an anti-Fas IgM antibody as an active ingredient to alleviate osteoarthritis symptoms by inhibiting the production of cartilage matrix degrading enzymes and by increasing the production of cartilage matrix.
    Type: Application
    Filed: January 27, 2011
    Publication date: February 7, 2013
    Applicant: AXIS INC.
    Inventors: Kusuki Nishioka, Kazuo Yudo
  • INJECTABLE SOLUTION CONTAINING THERAPEUTIC AGENT FOR OSTEOARTHRITIS
    Publication number: 20130011416
    Abstract: Injections for treating and preventing diseases classified as any of grade 1 to 3 according to the ICRS classification of osteoarthritis, diseases classified as any of grade 1 to 3 according to the Kellgren-Lawrence classification of osteoarthritis or diseases classified as any of grade 1 to 3 according to the Outerbridge classification of osteoarthritis contain anti-Fas IgM antibody as an active ingredient and a pharmaceutically acceptable carrier to alleviate osteoarthritis symptoms by inhibiting the production of cartilage matrix degrading enzymes and by increasing the production of cartilage matrix.
    Type: Application
    Filed: January 27, 2011
    Publication date: January 10, 2013
    Applicant: AXIS INC.
    Inventors: Kusuki Nishioka, Kazuo Yudo
  • PHARMACEUTICAL COMPOSITION FOR TREATMENT OR PREVENTION OF OSTEOARTHRITIS, AND METHOD OF PRODUCTION THEREFOR
    Publication number: 20130011407
    Abstract: Pharmaceutical compositions for treating or preventing diseases classified as any of grade 1 to 3 according to the ICRS classification of osteoarthritis, classified as any of grade 1 to 3 according to the Kellgren-Lawrence classification of osteoarthritis or classified as any of grade 1 to 3 according to the Outerbridge classification of osteoarthritis and methods of manufacturing same contain anti-Fas IgM antibody as an active ingredient and a pharmaceutically acceptable carrier with acidity of pharmaceutical compositions ranging from pH 4 to pH 9 to alleviate osteoarthritis symptoms by inhibiting the production of cartilage matrix degrading enzymes and by increasing the production of cartilage matrix.
    Type: Application
    Filed: January 27, 2011
    Publication date: January 10, 2013
    Applicant: AXIS INC.
    Inventors: Kusuki Nishioka, Kazuo Yudo
  • THERAPEUTIC AGENT OR PREVENTIVE AGENT FOR OSTEOARTHRITIS
    Publication number: 20110182915
    Abstract: A method for treatment of disease classified as any of grade 1 to 3 according to the ICRS classification of osteoarthritis, any of grade 1 to 3 according to the Kellgren-Lawrence classification of osteoarthritis, or any of grade 1 to 3 according to the Outerbridge classification of osteoarthritis, the method includes a step of administrating an agent containing an anti-Fas IgM antibody as an active ingredient.
    Type: Application
    Filed: July 31, 2009
    Publication date: July 28, 2011
    Applicant: AXIS, INC.
    Inventors: Kusuki Nishioka, Kazuo Yudo